STOCK TITAN

Vanguard (PODD) parent reports 0 shares after realignment; subsidiaries to report

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

The Vanguard Group filed Amendment No. 14 to Schedule 13G/A reporting that it beneficially owns 0 shares of Insulet Corp Common Stock, representing 0% of the class as disclosed in the amendment.

The amendment explains an internal realignment effective January 12, 2026, under SEC Release No. 34-39538 that resulted in certain subsidiaries and business divisions of The Vanguard Group reporting ownership separately. The filing is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026.

Positive

  • None.

Negative

  • None.

Insights

Vanguard reports zero beneficial ownership in Insulet after internal realignment.

The amendment states The Vanguard Group's subsidiaries now report holdings separately following an internal realignment referenced to SEC Release No. 34-39538, and the parent reports 0 shares and 0% ownership as of the filing.

Cash-flow treatment or which specific subsidiaries now report holdings is not detailed in the excerpt; subsequent disclosures by the separate reporting entities would show where prior holdings are now recorded.

Amendment documents administrative reallocation of reporting responsibility, not an economic sale.

The filing cites an internal realignment dated 01/12/2026 and explains that certain subsidiaries will report beneficial ownership separately, in reliance on SEC Release No. 34-39538.

This filing itself lists ownership as 0 shares; any investor impact depends on disclosures by the subsidiaries that now hold or report the position.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/27/2026

FAQ

Does The Vanguard Group own Insulet Corp (PODD) shares according to this filing?

No, the filing states The Vanguard Group beneficially owns 0 shares of Insulet common stock. The amendment reports 0% ownership and attributes reporting changes to an internal realignment under SEC Release No. 34-39538.

What caused The Vanguard Group to report 0 shares in the Schedule 13G/A amendment?

An internal realignment on 01/12/2026 caused certain subsidiaries to report holdings separately. The amendment says the parent no longer is deemed to beneficially own securities held by those subsidiaries.

When was the Schedule 13G/A Amendment No. 14 signed for PODD?

The amendment is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026. The filing cites the realignment date of 01/12/2026 in its explanation.

Does this Schedule 13G/A indicate a sale of Insulet shares by Vanguard?

No, the amendment attributes the change to an internal reporting realignment under SEC Release No. 34-39538 rather than describing any sale or transfer of economic ownership. The filing reports 0 shares for the parent.

Will other Vanguard entities report Insulet holdings after this amendment?

Yes; the amendment states certain subsidiaries or business divisions will report beneficial ownership separately in reliance on SEC Release No. 34-39538. Which subsidiaries will report is not listed in this excerpt.
Insulet Corp

NASDAQ:PODD

View PODD Stock Overview

PODD Rankings

PODD Latest News

PODD Latest SEC Filings

PODD Stock Data

15.35B
70.13M
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
ACTON